Open AccessPlatelet Dysfunction in Intraparenchymal Hemorrhage
Author(s) -
Claire J. Creutzfeldt,
Kyra J. Becker,
W. T. Longstreth,
David Tirschwell,
Jonathan R. Weinstein
Publication year - 2009
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.109.561191
Subject(s) - medicine , intraparenchymal hemorrhage , surgery , general surgery , subarachnoid hemorrhage
To the Editor:The Cerebral Hematoma And NXY Treatment (CHANT) investigators found no association between the use of antiplatelet therapy (APT) and intraparenchymal hemorrhage (IPH) volume, growth, or outcome. In the paper and accompanying editorial, authors concluded that acute reversal of antiplatelet medications was not justified.1,2⇓ The literature on the topic yields conflicting results with some papers3–6⇓⇓⇓ supporting an association between APT and outcome from IPH and others not.1,7–9⇓ …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom